These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21084212)

  • 1. Oseltamivir-induced dyskinesia in Parkinson's disease.
    Kadowaki T; Komagamine T; Suzuki K; Hirata K
    Parkinsonism Relat Disord; 2011 Feb; 17(2):133-4. PubMed ID: 21084212
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal bidirectional plasticity-like effects in Parkinson's disease.
    Huang YZ; Rothwell JC; Lu CS; Chuang WL; Chen RS
    Brain; 2011 Aug; 134(Pt 8):2312-20. PubMed ID: 21742734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety profile of oseltamivir during the 2009 influenza pandemic.
    Donner B; Bader-Weder S; Schwarz R; Peng MM; Smith JR; Niranjan V
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):532-43. PubMed ID: 21448900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyskinesia-induced postural instability in Parkinson's disease.
    Armand S; Landis T; Sztajzel R; Burkhard PR
    Parkinsonism Relat Disord; 2009 Jun; 15(5):359-64. PubMed ID: 18851925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L; Yahr MD; Marinelli L; Huang N; Moshier E; Di Rocco A
    Parkinsonism Relat Disord; 2005 May; 11(3):151-5. PubMed ID: 15823479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG; Damier P; Hicking C; Laska E; Müller T; Olanow CW; Rascol O; Russ H
    Mov Disord; 2007 Jan; 22(2):179-86. PubMed ID: 17094088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.
    Paillé V; Henry V; Lescaudron L; Brachet P; Damier P
    Mov Disord; 2007 Mar; 22(4):533-9. PubMed ID: 17230470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.
    Olanow CW; Gracies JM; Goetz CG; Stoessl AJ; Freeman T; Kordower JH; Godbold J; Obeso JA
    Mov Disord; 2009 Feb; 24(3):336-43. PubMed ID: 19006186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spiral drawing during self-rated dyskinesia is more impaired than during self-rated Off.
    Memedi M; Westin J; Nyholm D
    Parkinsonism Relat Disord; 2013 May; 19(5):553-6. PubMed ID: 23402993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 11. Online monitoring of dyskinesia in patients with Parkinson's disease.
    Keijsers NL; Horstink MW; Gielen SC
    IEEE Eng Med Biol Mag; 2003; 22(3):96-103. PubMed ID: 12845825
    [No Abstract]   [Full Text] [Related]  

  • 12. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis.
    Siedler K; Skopnik H
    Pediatr Infect Dis J; 2010 Jun; 29(6):495-8. PubMed ID: 20035245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemiballism after subthalamotomy in patients with Parkinson's disease: report of 2 cases.
    Chen CC; Lee ST; Wu T; Chen CJ; Huang CC; Lu CS
    Mov Disord; 2002 Nov; 17(6):1367-71. PubMed ID: 12465086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variance in effects of subthalamic nucleus stimulation].
    Okiyama R; Yokochi F; Taniguchi M; Takahashi H; Hasegawa N; Hamada I
    No To Shinkei; 2002 Oct; 54(10):883-8. PubMed ID: 12476577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials.
    Berg D; Godau J; Trenkwalder C; Eggert K; Csoti I; Storch A; Huber H; Morelli-Canelo M; Stamelou M; Ries V; Wolz M; Schneider C; Di Paolo T; Gasparini F; Hariry S; Vandemeulebroecke M; Abi-Saab W; Cooke K; Johns D; Gomez-Mancilla B
    Mov Disord; 2011 Jun; 26(7):1243-50. PubMed ID: 21484867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
    Maurel F; Lilliu H; Le Pen C
    Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments.
    Metman LV; Myre B; Verwey N; Hassin-Baer S; Arzbaecher J; Sierens D; Bakay R
    Mov Disord; 2004 Sep; 19(9):1079-1084. PubMed ID: 15372601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyskinesia caused by L-DOPA].
    Derkinderen P; Vidailhet M
    Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S92-101. PubMed ID: 12690668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir: gastrointestinal bleeding. Unfavorable risk-benefit balance.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19536940
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.